Ranking Invest

GKOS - Glaukos Corporation

Segmento: HealthcareGlaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.

Análise Ranking Invest

Valuation estimado
$ 364.85 Mi
Valor de Mercado
$ 5.22 Bi
Sobrepreço (AV)+1330.9%
MLL
-0.08A companhia gerou lucro líquido equivalente a -8% do seu valor de mercado nos últimos 4 trimestres.
Último Balanço Atualizado: 1T2025

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 763.96 Mi

Dívida Líquida

-$ 8.77 Mi

L4T

-$ 123.68 Mi

MM4T

-30.95%

Indicadores Básicos

ROE

-16.19%

Índices de Previsibilidade

Faturamento

0.07

Lucro

0.44

Margem

0.48

Índices de Tendência

Faturamento

10.12

Lucro

-5.51

Margem

-3.41

Índices de Endividamento

DIV/PAT

-0.01

DIV/L4T

0.07

Dívidas
Cotação
Gráfico Lucro/Faturamento X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.